摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(2-hydroxy-2-methylpropyl)-8-methoxy-3-(3-methoxy-4-nitrophenyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one | 755029-85-7

中文名称
——
中文别名
——
英文名称
7-(2-hydroxy-2-methylpropyl)-8-methoxy-3-(3-methoxy-4-nitrophenyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one
英文别名
2-(2-Hydroxy-2-methylpropyl)-3-methoxy-9-(3-methoxy-4-nitrophenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one
7-(2-hydroxy-2-methylpropyl)-8-methoxy-3-(3-methoxy-4-nitrophenyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one化学式
CAS
755029-85-7
化学式
C25H25N3O6
mdl
——
分子量
463.49
InChiKey
CWSWWLGVJROEDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    34
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    126
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    3-甲氧基-4-硝基苯硼酸频那醇酯 、 3-chloro-7-(2-hydroxy-2-methylpropyl)-8-methoxy-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one 在 palladium diacetate cesium fluoride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以68%的产率得到7-(2-hydroxy-2-methylpropyl)-8-methoxy-3-(3-methoxy-4-nitrophenyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one
    参考文献:
    名称:
    Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors
    摘要:
    The synthesis and structure-activity relationships (SAR) of Chk1 inhibitors based on a 5,10-dihydro-dibenzo[b,e][1,4] diazepin-11-one core are described. Specifically, an exploration of the 7 and 8 positions on this previously disclosed core afforded compounds with improved enzymatic and cellular potency. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.02.080
点击查看最新优质反应信息

文献信息

  • Heterocyclic kinase inhibitors
    申请人:——
    公开号:US20040254159A1
    公开(公告)日:2004-12-16
    Compounds having the formula 1 are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    具有1式的化合物对于抑制蛋白激酶非常有用。还揭示了制备该化合物的方法,含有该化合物的组合物,以及使用该化合物进行治疗的方法。
  • Heterocyclic Kinase Inhibitors
    申请人:Hasvold A. Lisa
    公开号:US20070254867A1
    公开(公告)日:2007-11-01
    Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    具有公式的化合物对于抑制蛋白激酶很有用。还公开了制备这些化合物的方法、含有这些化合物的组合物和使用这些化合物的治疗方法。
  • 5,10-DIHYDRO-11H-DIBENZO[B,E][1,4]DIAZEPIN-11-ONE AS KINASE INHIBITORS
    申请人:AbbVie Inc.
    公开号:EP1606268B1
    公开(公告)日:2015-05-20
  • US7456169B2
    申请人:——
    公开号:US7456169B2
    公开(公告)日:2008-11-25
  • Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors
    作者:Lisa A. Hasvold、Le Wang、Magdalena Przytulinska、Zhan Xiao、Zehan Chen、Wen-Zhen Gu、Philip J. Merta、John Xue、Peter Kovar、Haiying Zhang、Chang Park、Thomas J. Sowin、Saul H. Rosenberg、Nan-Horng Lin
    DOI:10.1016/j.bmcl.2008.02.080
    日期:2008.4
    The synthesis and structure-activity relationships (SAR) of Chk1 inhibitors based on a 5,10-dihydro-dibenzo[b,e][1,4] diazepin-11-one core are described. Specifically, an exploration of the 7 and 8 positions on this previously disclosed core afforded compounds with improved enzymatic and cellular potency. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多